EcoDrugPlus

40s Ribosomal Protein S5

Ensembl ID : ENSELUG00000007427
Gene Symbol: RS5
3 Cross references
256 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSELUG00000010762
Gene Symbol: LOC105028350
4 Cross references
504 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSELUG00000034180
Gene Symbol: LOC105012295
3 Cross references
506 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSELUG00000001105
Gene Symbol: NT5E
3 Cross references
198 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSELUG00000013987
Gene Symbol: HTR1B
1 Cross references
180 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSELUG00000016168
Gene Symbol: HTR1B
1 Cross references
178 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSELUG00000016618
Gene Symbol: HTR1E
3 Cross references
145 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSELUG00000013534
Gene Symbol: HTR1E
4 Cross references
115 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSELUG00000004888
Gene Symbol: HTR2B
3 Cross references
204 Possible Orthologues:

5-Hydroxytryptamine Receptor 2c

Ensembl ID : ENSELUG00000026854
Gene Symbol: LOC105007309
3 Cross references
202 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSELUG00000014735
Gene Symbol: HTR3A
1 Cross references
205 Possible Orthologues:

5-Hydroxytryptamine Receptor 3b

Ensembl ID : ENSELUG00000014709
Gene Symbol: HTR3B
1 Cross references
175 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).